Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona

September 10, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 10 /- Varian Medical Systems (NYSE: VAR ) is spotlighting its new TrueBeam™ medical linear accelerator for fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A...

Business & Decision North America Announces the Successful Go-Live of Microsoft Dynamics AX at DeVilbiss Healthcare

September 9, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa., Sept. 9 /- DeVilbiss Healthcare has selected Business & Decision, following a thorough selection process, to ensure the successful implementation of its Microsoft Dynamics AX solution. As part of the separation from Sunrise Medical, DeVilbiss sought to select and implement...

HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock

September 9, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala., Sept. 9 /- HealthSouth Corporation (NYSE: HLS ) announced today that its board of directors has declared a regular quarterly dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on Oct. 15, 2010, to holders of record on Oct. 1,...

Advertisement

Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences

September 9, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

CRANBURY, N.J., Sept. 9 /- Cornerstone Pharmaceuticals, Inc., the cancer metabolism company, today announced that its CEO, Robert Shorr, Ph.D., D.I.C., will be speaking and Co-Chairing The Center for Business Intelligence's (CBI's) 4th Annual Oncology Clinical Trials Summit and chairing a...

Use of medication for insomnia or anxiety increases mortality risk by 36 percent

September 9, 2010 12:31 am | by EurekAlert | News | Comments

(Université Laval) Taking medications to treat insomnia and anxiety increases mortality risk by 36 percent, according to a study conducted by Geneviève Belleville, a professor at Université Laval's School of Psychology. The details of this study are published in the latest edition of the...

Using chest compressions first just as successful as immediate defibrillation after cardiac arrest

September 8, 2010 9:34 pm | by EurekAlert | News | Comments

(University of Michigan Health System) In cardiac arrest, is it best to start pumping on the victim's chest or give an immediate shock to the heart? The University of Michigan learns both rescue strategies are effective, yet chest compressions before defibrillation may be best in events...

Masimo to Present at Stifel Nicolaus 2010 Healthcare Conference

September 8, 2010 1:34 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 8 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Stifel Nicolaus 2010 Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 15, at 8:00 a.m. ET.  A live audiocast of the presentation will...

BCM Human Genome Sequencing Center joins NIH's Pharmacogenomics Research Network

September 7, 2010 10:33 am | by Baylor College of Medicine | News | Comments

The Baylor College of Medicine Human Genome Sequencing Center has received a five-year, $2.3 million grant to join the National Institutes of Health's Pharmacogenomics Research Network , a collaborative project that seeks to advance research on how genes affect people's responses to a...

Advertisement

Study finds more Americans bypassing their personal physician when immediate treatment required

September 7, 2010 8:34 am | by EurekAlert | News | Comments

(Emory University) Only 45 percent of the 354 million annual visits for acute care in the United States are made to patients' personal physicians, as Americans increasingly make busy emergency departments, specialists or outpatient care departments their first point of contact for...

Researchers identify how bone-marrow stem cells hold their 'breath' in low-oxygen environments

September 2, 2010 10:31 pm | by EurekAlert | News | Comments

(UT Southwestern Medical Center) UT Southwestern Medical Center researchers have identified unique metabolic properties that allow a specific type of stem cell in the body to survive and replicate in low-oxygen environments.

Scientists discover the mechanisms and function of a type of mysterious immune cell

September 2, 2010 1:32 pm | by EurekAlert | News | Comments

(Scripps Research Institute) In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat...

Lung cancer survival rates improved through use of individualized chemotherapy

August 31, 2010 9:32 pm | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing...

Tumor budding identified as predictor for unfavorable outcome in lung cancer

August 31, 2010 9:32 pm | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years.

Advertisement

Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery

August 31, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 31 /- Masimo (Nasdaq: MASI ) announced today that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in...

Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study

August 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Aug. 30 /- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of new data supporting the safety and efficacy of Caldolor® ( ibuprofen ) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the...

Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles

August 30, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

BEND, Ore., Aug. 30 /- Bend Research Inc. ( www.bendres.com ), a leading independent drug-formulation development and manufacturing company, announced today that it has received a new U.S. patent covering a process for making spray-dried solid amorphous dispersions of drugs using pressure...

Covidien Completes Sale of Sleep Therapy Product Line

August 30, 2010 3:32 am | by Covidien | News | Comments

DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a...

New genomic marker for tuberculosis may help identify patients who will develop the disease

August 29, 2010 10:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the Aug. 19 issue of Nature and conducted by...

Shire Announces European Approval of VPRIV & #174; (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

August 27, 2010 6:33 am | by RealWire | News | Comments

Cambridge, MA, US - August, 27th 2010 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV® (velaglucerase alfa), a human cell line derived enzyme replacement...

JCI table of contents: Aug. 25, 2010

August 25, 2010 2:32 pm | by EurekAlert | News | Comments

(Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for papers to be published Aug. 25, 2010, in the JCI: Applying stem cell technology to liver diseases; Antifreeze molecule enhances survival of bacteria-carrying ticks; Immune...

Use the common cold virus to target and disrupt cancer cells?

August 25, 2010 2:31 pm | by EurekAlert | News | Comments

(Salk Institute) A novel mechanism used by adenovirus to sidestep the cell's suicide program, could go a long way to explain how tumor suppressor genes are silenced in tumor cells and pave the way for a new type of targeted cancer therapy, report researchers at the Salk Institute for...

Echo Therapeutics Announces Successful Completion of Clinical Trial for Preludeâ„¢ SkinPrep System and 4% Lidocaine Cream

August 24, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Aug. 24 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphonyâ„¢ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Preludeâ„¢ SkinPrep System for transdermal drug...

Hospira Japan Receives Approval for New Indication for 'Precedex IVâ„¢ 200ug'

August 22, 2010 8:34 pm | by Bio-Medicine.Org | News | Comments

OSAKA, Japan, Aug. 22 /- Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this...

New 'Heroes of Chemistry' invented medicines that help millions of people

August 22, 2010 4:34 pm | by EurekAlert | News | Comments

(American Chemical Society) It's a tale of two pills: One that helps millions of people with diabetes maintain normal blood sugar levels and another that helps millions in their effort to quit smoking. The two teams that invented these potentially life-saving drugs -- Januvia and Chantix...

Cigarette smoke causes harmful changes in the lungs even at the lowest levels

August 19, 2010 9:32 pm | by EurekAlert | News | Comments

(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) Casual smokers may think that smoking a few cigarettes a week is "no big deal." But according to new research from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading